Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-04-14

FDA Approved: KAPSPARGO — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approves a supplemental application for KAPSPARGO (metoprolol succinate) by Sun Pharmaceutical Industries.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • KAPSPARGO (METOPROLOL SUCCINATE)

Snippet

SUPPL AP for KAPSPARGO (METOPROLOL SUCCINATE)